Economic evaluation of plerixafor for stem cell mobilization.
about
Concise review: Sowing the seeds of a fruitful harvest: hematopoietic stem cell mobilizationUS-Based Drug Cost Parameter Estimation for Economic Evaluations.HIF-1α is required for hematopoietic stem cell mobilization and 4-prolyl hydroxylase inhibitors enhance mobilization by stabilizing HIF-1α.Hematopoietic progenitor cell mobilization with "just-in-time" plerixafor approach is a cost-effective alternative to routine plerixafor use.Hematopoietic progenitor cell mobilization for autologous transplantation - a literature review.Chemical Stability of Plerixafor after Opening of Single-Use Vial.
P2860
Economic evaluation of plerixafor for stem cell mobilization.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Economic evaluation of plerixafor for stem cell mobilization.
@en
type
label
Economic evaluation of plerixafor for stem cell mobilization.
@en
prefLabel
Economic evaluation of plerixafor for stem cell mobilization.
@en
P2093
P2860
P1476
Economic evaluation of plerixafor for stem cell mobilization.
@en
P2093
Dennis L Lambert
Iskra Pusic
John F DiPersio
Kenneth R Carson
Martin Gregory
Steven M Kymes
P2860
P577
2012-01-01T00:00:00Z